Advertisement

Topics

MEDIVIR AB Company Profile

12:26 EDT 21st June 2018 | BioPortfolio

Medivir develops drugs against major, widespread diseases, based on proteases as the target enzyme. Its objective is to be a sustainable and profitable research-based pharmaceutical company with products on the market that it has developed in-house. Medivir was founded in 1988.In Sweden, the company is located in Huddinge, near Stockholm, and in the UK, at Chesterford Research Park, Essex.The group comprises Medivir AB, its subsidiary Medivir UK Ltd., Medivir HIV Franchise AB and Medivir Personal AB.
Medivir was listed on the Stockholm Stock Exchange O-list in 1996.
Medivir had a staff headcount of 133 on 31 December 2005.
In December 2005, Medivir's board of directors decided to focus operations, and to take its ME-609 (labial herpes) project into phase III studies towards market registration. At this point, Medivir HIV Franchise AB was incorporated, whose purpose is to divest Medivir's polymerase-based projects against HIV, hepatitis B and shingles, and to concentrate research within the parent company on protease-based projects.

Location

Lunastigen7
Huddinge
SE-141 44
Sweden

Contact

Phone: 46 (0)8 5468 3100
Fax: 46 (0)8 5468 3199
Email: medivir@medivir.se


News Articles [15 Associated News Articles listed on BioPortfolio]

Medivir's Annual Report for 2017 is Published

In 2017, Medivir could present groundbreaking results from the company's first phase IIa study with MIV-711 for the treatment of osteoarthritis. In oncology, Medivir's focus Read more...

AMR Centre Swedish deal targets ‘superbug’ time-bomb

Alderley Park, England, and Stockholm, Sweden - Medivir AB (Nasdaq Stockholm: MVIR) and AMR Centre Ltd (AMRC) 5th October, announce signing of an agreement providing AMRC the exclusive worldwide right...

Biotech turns Pharma: Medivir's continuing evolution.

Medivir’s Business Development Director, Morten Faester talks to Fintan Walton at AngloNordic Life Science Conference, 2014 in London. Astra’s antiviral spinout has licensed a cold sore product ...

Medivir AB Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 18022018] Prices from USD $350

Medivir AB Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Medivir AB Mergers Acquisitions MA, Partnerships Alliances and Investments report includes busi...

Medivir delays remetinostat Phase III

Medivir licenses HCV drug MIV-802 to Chinese Ascletis

Medivir skjuter upp studie

Bolaget fortsätter att diskuterar utformning med FDA varför den kliniska studien skjuts upp till tidigast nästa år.

Medivir Announces Departure of Chief Medical Officer

"Over the last four years, John has been responsible for shaping the clinical pipeline we have today and recruiting the clinical development team that is Read more...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Xerese [Meda Pharmaceuticals Inc.]

These highlights do not include all the information needed to use XERESE™ (acyclovir and hydrocortisone) Cream 5%/1% safely and effectively. See full prescribing information for XERESE. XERESE™ (a...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Medivir Medivir AB

Medivir is an emerging research-based pharmaceutical company focused on infectious diseases.

MEDIVIR AB

Medivir develops drugs against major, widespread diseases, based on proteases as the target enzyme. Its objective is to be a sustainable and profitable research-based pharmaceutical company with produ...

Medivir

The group consists of Medivir AB, the subsidiaries Medivir UK Ltd., CCS AB and Medivir Personal AB, as well as the second-tier subsidiaries CCS (UK) Ltd. and Nordic Care Sweden AB. At year end 2001, t...

More Information about "MEDIVIR AB" on BioPortfolio

We have published hundreds of MEDIVIR AB news stories on BioPortfolio along with dozens of MEDIVIR AB Clinical Trials and PubMed Articles about MEDIVIR AB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MEDIVIR AB Companies in our database. You can also find out about relevant MEDIVIR AB Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Enzymes
Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into different molecules, called products. Almost all chemical re...


Corporate Database Quicklinks



Searches Linking to this Company Record